Astrobotic clears wireless charging system for moon missions with help from WiBotic
Astrobotic says it has completed flight model acceptance testing for a wireless charging system that incorporates technology from Seattle-based WiBotic — and that could help rovers roam across the surface of the moon.
The system is designed to provide reliable, high-efficiency power transfer amid the extreme conditions of the lunar surface, including a night that lasts 14 Earth days. It was developed by Pittsburgh-based Astrobotic and WiBotic with assistance from the University of Washington, Bosch and NASA's Glenn Research Center.
'This is the foundation for a unified, interoperable power standard for the moon and Mars,' Astrobotic CEO John Thornton said in a news release. 'We're offering a wireless charging solution that can support cross-agency, cross-industry missions, built to survive the harshest planetary environments. If your assets need dependable power on the surface, this is the plug they'll need.'
WiBotic's co-founder and CEO, Ben Waters, said the system's successful qualification is a 'major step forward.'
'For the first time, there's an off-the-shelf, space-qualified wireless charging solution available for lunar and orbital missions,' Waters said in a LinkedIn post. 'Instead of spending years developing a custom charger for each robot, tool or power system, companies can now integrate a proven solution that works across battery types, voltages and devices — no physical connectors required.'
An artist's conception shows a lunar rover and a row of charging stations. (WiBotic Illustration)
The wireless system is designed to deliver power from an Astrobotic lunar lander or from a Vertical Solar Array Technology platform, also known as VSAT. Power from the source would be converted to wireless power by a WiBotic transmitter circuit, and then sent to the device by a transmitter antenna coil.
Such a system would be well-suited for lunar operations — where devices would otherwise have to be repeatedly connected and disconnected, subjecting them to wear and tear from abrasive moon dust.
The acceptance testing process for the wireless charger flight model was conducted over the course of four months at Astrobotic's Pittsburgh headquarters and at Glenn Research Center in Cleveland. The model was tested to check for electromagnetic interference and for the ability to cope with the vibrations that would be experienced during launch. The system also was subjected to vacuum conditions and the cold, dirty environment that would be encountered on the lunar surface.
Development of the system was supported by a NASA Tipping Point contract. A 125-watt wireless charger model is now commercially available for advanced power solutions in space applications, and a 400-watt model is undergoing further testing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Prologis (PLD) To Add 4000 Homes with Caltrain Site Revamp
Prologis, Inc. (NYSE:PLD) is one of the most undervalued stocks. Prologis recently indicated its intention to file redevelopment plans later this year for the Caltrain railyards located at Fourth and King Street. The REIT is proposing a seven-million-square-foot mixed-use project that could accommodate between 1,500 and 4,000 residential units. As reported by the San Francisco Business Times, if fully executed, the development would represent one of the most significant housing initiatives near a major transit corridor in San Francisco. The Business Times noted that the variability in potential housing units offers Prologis the agility to align the project with future demand. Although formal approvals are unlikely before 2027, planning commissioners are already highlighting the importance of affordability. A large logistic facility within the industrial real estate sector. Prologis Vice President Genevieve Cadwalader commented that residential development will be a focal element in the transformation of the railyards into a high-density, transit-oriented urban district. This project holds the potential to be San Francisco's second most densely developed transit-centric neighborhood, following the Transbay district. Prologis, Inc. (NYSE:PLD) is a global REIT focused on high-barrier, high-growth markets in 20 countries. Prologis leases modern logistics facilities to a diverse base of customers across two major categories – business-to-business and retail/online fulfillment. While we acknowledge the potential of PLD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
Medscape
14 minutes ago
- Medscape
Officials Brace for New Normal of Dengue Cases
As summer ushers in peak mosquito season, health and vector control officials are bracing for the possibility of another year of historic rates of dengue. And with climate change, the lack of an effective vaccine, and federal research cuts, they worry the disease will become endemic to a larger swath of North America. About 3700 new dengue infections were reported last year in the contiguous United States, up from about 2050 in 2023, according to the Centers for Disease Control and Prevention. All of last year's cases were acquired abroad, except for 105 cases contracted in California, Florida, or Texas. The CDC issued a health alert in March warning of the ongoing risk of dengue infection. 'I think dengue is here with us to stay,' said infectious disease specialist Michael Ben-Aderet, associate medical director of hospital epidemiology at Cedars-Sinai in Los Angeles, about dengue becoming a new normal in the US. 'These mosquitoes aren't going anywhere.' Dengue is endemic — a label health officials assign when diseases appear consistently in a region — in many warmer parts of the world, including Latin America, India, and Southeast Asia. Dengue cases increased markedly last year in many of those places, especially in Central and South America. The disease, which can spread when people are bitten by infected Aedes mosquitoes, was not common in the contiguous United States for much of the last century. Today, most locally acquired (meaning unrelated to travel) dengue cases in the US happen in Puerto Rico, which saw a sharp increase in 2024, triggering a local public health emergency. Most people who contract dengue don't get sick. But in some people symptoms are severe: bleeding from the nose or mouth, intense stomach pain, vomiting, and swelling. Occasionally, dengue causes death. California offers a case study in how dengue is spreading in the US. The Aedes aegypti and Aedes albopictus mosquitoes that transmit dengue weren't known to be in the state 25 years ago. They are now found in 25 counties and more than 400 cities and unincorporated communities, mostly in Southern California and the Central Valley. The spread of the mosquitoes is concerning because their presence increases the likelihood of disease transmission, said Steve Abshier, president of the Mosquito and Vector Control Association of California. From 2016 through 2022, there were an average of 136 new dengue cases a year in California, each case most likely brought to the state by someone who had traveled and been infected elsewhere. In 2023, there were about 250 new cases, including two acquired locally. In 2024, California saw 725 new dengue cases, including 18 acquired locally, state data shows. Climate change could contribute to growth in the Aedes mosquitoes' population, Ben-Aderet said. These mosquitoes survive best in warm urban areas, often biting during the daytime. Locally acquired infections often occur when someone catches dengue during travel, then comes home and is bitten by an Aedes mosquito that bites and infects another person. 'They've just been spreading like wildfire throughout California,' Ben-Aderet said. Dengue presents a challenge to the many primary care doctors who have never seen it. Ben-Aderet said doctors who suspect dengue should obtain a detailed travel history from their patients, but confirming the diagnosis is not always quick. 'There's no easy test for it,' he said. 'The only test that we have for dengue is antibody tests.' He added that 'most labs probably aren't doing it commercially, so it's usually like a send-out test from most labs. So, you really have to suspect someone has dengue.' Best practices for avoiding dengue include eliminating any standing pools of water on a property — even small pools — and using mosquito repellent, Abshier said. Limiting activity at dusk and dawn, when mosquitoes bite most often, can also help. Efforts to combat dengue in California became even more complicated this year after wildfires ripped through Los Angeles. The fires occurred in a hot spot for mosquito-borne illnesses. San Gabriel Valley Mosquito and Vector Control District officials have worked for months to treat more than 1400 unmaintained swimming pools left in the wake of fire, removing potential breeding grounds for mosquitoes. San Gabriel vector control officials have used local and state resources to treat the pools, said district spokesperson Anais Medina Diaz. They have applied for reimbursement from the Federal Emergency Management Agency, which has not historically paid for vector control efforts following wildfires. In California, vector control agencies are often primarily funded by local taxes and fees on property owners. Some officials are pursuing the novel method of releasing sterilized Aedes mosquitoes to reduce the problem. That may prove effective, but deploying the method in a large number of areas would be costly and would require a massive effort at the state level, Abshier said. Meanwhile, the federal government is pulling back on interventions: Several outlets have reported that the National Institutes of Health will stop funding new climate change-related research, which could include work on dengue. This year, reported rates of dengue in much of the Americas have declined significantly from 2024. But the trend in the United States likely won't be clear until later in the year, after the summer mosquito season ends. Health and vector control researchers aren't sure how bad it will get in California. Some say there may be limited outbreaks, while others predict dengue could get much worse. Sujan Shresta, a professor and infectious disease researcher at the La Jolla Institute for Immunology, said other places, like Nepal, experienced relatively few cases of dengue in the recent past but now regularly see large outbreaks. There is a vaccine for children, but it faces discontinuation from a lack of global demand. Two other dengue vaccines are unavailable in the United States. Shresta's lab is hard at work on an effective, safe vaccine for dengue. She hopes to release results from animal testing in a year or so; if the results are positive, human trials could be possible in about 2 years. 'If there's no good vaccine, no good antivirals, this will be a dengue-endemic country,' she said. Phillip Reese is a data reporting specialist and an associate professor of journalism at California State University-Sacramento.
Yahoo
15 minutes ago
- Yahoo
BTCS Acquires 1,000 ETH via AAVE to Fuel NodeOps Expansion
BTCS Inc. (NASDAQ:BTCS) is among the best growth stocks to invest in for the next 5 years. According to a press release issued on Friday, BTCS Inc. (NASDAQ:BTCS) has announced the acquisition of 1,000 ether (ETH) for around $2.5 million via borrowing on decentralized lending protocol AAVE. This would allow the blockchain technology company to support the expansion of its NodeOps business by utilizing the newly acquired ether. This transaction, with an average price of $2,528 per ETH, means that BTCS Inc. (NASDAQ:BTCS) now owns 14,600 ETH, implying a surge of 61% from the existing 9,063 ETH held at the end of the first quarter of 2025. As the CEO of BTCS Inc., Charles Allen, stated, 'Our approach has always been slow, steady, and strategic.' Through AAVE's lending platform, the company protected shareholder interest, with the initial net cost of capital noted to be around 2.78% per year. Just recently, FTSE Russell posted its preliminary list of companies slated to join the Russell Microcap Index, with BTCS Inc. (NASDAQ:BTCS) included among the technology names. BTCS Inc. (NASDAQ:BTCS) is a Maryland-based company that offers blockchain infrastructure services in the United States. From Builder+ and NodeOps to ChainQ, the company has a diversified product portfolio. Founded in 2015, the company is dedicated to securing next-generation proof-of-stake blockchains. While we acknowledge the potential of BTCS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
